0001968582-24-000274.txt : 20240401 0001968582-24-000274.hdr.sgml : 20240401 20240401161732 ACCESSION NUMBER: 0001968582-24-000274 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240401 DATE AS OF CHANGE: 20240401 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Akero Therapeutics, Inc. CENTRAL INDEX KEY: 0001744659 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-38944 FILM NUMBER: 24809526 BUSINESS ADDRESS: STREET 1: 601 GATEWAY BOULEVARD, SUITE 350 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-487-6488 MAIL ADDRESS: STREET 1: 601 GATEWAY BOULEVARD, SUITE 350 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Young Jonathan CENTRAL INDEX KEY: 0001779805 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: C/O AKERO THERAPEUTICS, INC. STREET 2: 170 HARBOR WAY 3RD FL CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 144 1 primary_doc.xml 144 0001779805 XXXXXXXX LIVE 0001744659 Akero Therapeutics, Inc. 001-38944 601 Gateway Boulevard Suite 350 South San Francisco CA 94080 650-487-6488 Jonathan Young Officer Common Stock J.P. Morgan Securities LLC

390 Madison Avenue 6th Floor New York NY 10017

15000 379200 56297528 04/01/2024 NASDAQ Common Stock 01/13/2020 Stock Option Exercise Issuer N 15000 01/13/2020 Cash Y 04/01/2024 /s/ J.P. Morgan Securities LLC as agent and attorney-in-fact for Jonathan Young